ArticleOncotarget2017

Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cells.

Jun An et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.